| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/RuedaBA09 |
| P356 | DOI | 10.1021/CI8003732 |
| P932 | PMC publication ID | 2891173 |
| P698 | PubMed publication ID | 19434904 |
| P5875 | ResearchGate publication ID | 24420350 |
| P50 | author | Ruben Abagyan | Q44682954 |
| P2093 | author name string | Manuel Rueda | |
| Giovanni Bottegoni | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures | Q24545785 | ||
| Flexible ligand docking to multiple receptor conformations: a practical alternative | Q24650066 | ||
| A consensus view of protein dynamics | Q24682188 | ||
| Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution | Q27650851 | ||
| Molecular dynamics and protein function | Q28248486 | ||
| Docking essential dynamics eigenstructures | Q28258497 | ||
| Native proteins are surface-molten solids: application of the Lindemann criterion for the solid versus liquid state | Q28295069 | ||
| A hierarchy of timescales in protein dynamics is linked to enzyme catalysis | Q29616405 | ||
| Essential dynamics of proteins | Q29616843 | ||
| Pocketome via comprehensive identification and classification of ligand binding envelopes. | Q30350345 | ||
| Protein structures in virtual screening: a case study with CDK2. | Q30352402 | ||
| Novel procedure for modeling ligand/receptor induced fit effects. | Q30352584 | ||
| Normal modes and essential dynamics. | Q51887481 | ||
| ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility. | Q51933455 | ||
| Detailed ab initio prediction of lysozyme-antibody complex with 1.6 A accuracy. | Q52878047 | ||
| Ensemble docking into flexible active sites. Critical evaluation of FlexE against JNK-3 and beta-secretase. | Q53746377 | ||
| Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis | Q56688821 | ||
| Thorough Validation of Protein Normal Mode Analysis: A Comparative Study with Essential Dynamics | Q57975961 | ||
| Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors | Q58571868 | ||
| Locating the active sites of enzymes using mechanical properties | Q61836416 | ||
| Normal mode analysis of G-actin | Q70602553 | ||
| Harmonicity and anharmonicity in protein dynamics: a normal mode analysis and principal component analysis | Q70980716 | ||
| Flexibility analysis of enzyme active sites by crystallographic temperature factors | Q73218028 | ||
| Multiple protein structures and multiple ligands: effects on the apparent goodness of virtual screening results | Q80697151 | ||
| Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case | Q80850175 | ||
| Exploring the Essential Dynamics of B-DNA | Q86864345 | ||
| Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. | Q30357936 | ||
| Exploring experimental sources of multiple protein conformations in structure-based drug design. | Q30362194 | ||
| Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. | Q30370020 | ||
| Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins | Q30421728 | ||
| Electrostatic funneling of substrate in mitochondrial inner membrane carriers | Q30482734 | ||
| Dissection of the recognition properties of p38 MAP kinase. Determination of the binding mode of a new pyridinyl-heterocycle inhibitor family | Q31093553 | ||
| The role of dynamics in enzyme activity | Q33185384 | ||
| Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors | Q33228824 | ||
| Accommodating protein flexibility in computational drug design | Q33825095 | ||
| Protein dynamics from NMR. | Q34019517 | ||
| Normal modes as refinement parameters for the F-actin model | Q34128277 | ||
| Conformational changes observed in enzyme crystal structures upon substrate binding | Q34386848 | ||
| Flexible docking in solution using metadynamics | Q34396573 | ||
| Implications of protein flexibility for drug discovery | Q35167908 | ||
| Conformational flexibility models for the receptor in structure based drug design. | Q35181130 | ||
| Dynamics of different functional parts of bacteriorhodopsin: H-2H labeling and neutron scattering | Q36061363 | ||
| Protein-ligand docking: current status and future challenges | Q36544700 | ||
| Structure selection for protein kinase docking and virtual screening: homology models or crystal structures? | Q36638823 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Overcoming the inadequacies or limitations of experimental structures as drug targets by using computational modeling tools and molecular dynamics simulations | Q36931811 | ||
| Target flexibility: an emerging consideration in drug discovery and design | Q37240137 | ||
| Harmonic dynamics of proteins: normal modes and fluctuations in bovine pancreatic trypsin inhibitor | Q37549050 | ||
| Dynamics of a small globular protein in terms of low-frequency vibrational modes | Q37615047 | ||
| Molecular dynamics of biological macromolecules: a brief history and perspective | Q40603907 | ||
| The effect of multiple binding modes on empirical modeling of ligand docking to proteins | Q41666696 | ||
| Harmonic and anharmonic aspects in the dynamics of BPTI: A normal mode analysis and principal component analysis | Q42844242 | ||
| Induced-fit or preexisting equilibrium dynamics? Lessons from protein crystallography and MD simulations on acetylcholinesterase and implications for structure-based drug design | Q43081937 | ||
| A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE). | Q43181588 | ||
| Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP. | Q44784463 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Predictions of protein flexibility: first-order measures | Q46120384 | ||
| Representing receptor flexibility in ligand docking through relevant normal modes. | Q46211444 | ||
| Unveiling the full potential of flexible receptor docking using multiple crystallographic structures | Q46563192 | ||
| Prediction of the receptor conformation for iGluR2 agonist binding: QM/MM docking to an extensive conformational ensemble generated using normal mode analysis | Q46802286 | ||
| Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations | Q47430898 | ||
| Analysis of catalytic residues in enzyme active sites | Q47614986 | ||
| Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking | Q47669698 | ||
| Fully automated molecular mechanics based induced fit protein-ligand docking method. | Q51868440 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 716-725 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| P1476 | title | Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes | |
| P478 | volume | 49 |
| Q40496890 | A flexible docking scheme to explore the binding selectivity of PDZ domains |
| Q34402706 | ALiBERO: evolving a team of complementary pocket conformations rather than a single leader |
| Q51088846 | Applications of Normal Mode Analysis Methods in Computational Protein Design. |
| Q28484330 | Can the energy gap in the protein-ligand binding energy landscape be used as a descriptor in virtual ligand screening? |
| Q37848281 | Challenges and advances in computational docking: 2009 in review |
| Q30423071 | Compound activity prediction using models of binding pockets or ligand properties in 3D. |
| Q34440071 | Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors |
| Q35630615 | Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures |
| Q34120783 | Discrete molecular dynamics distinguishes nativelike binding poses from decoys in difficult targets |
| Q39096521 | Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping |
| Q24633124 | Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules |
| Q90353407 | Druggability Simulations and X-Ray Crystallography Reveal a Ligand-Binding Site in the GluA3 AMPA Receptor N-Terminal Domain |
| Q41488333 | ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability |
| Q51532081 | Efficient inclusion of receptor flexibility in grid-based protein-ligand docking. |
| Q30437388 | GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex |
| Q44622243 | Generation of receptor structural ensembles for virtual screening using binding site shape analysis and clustering |
| Q56984187 | How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis |
| Q30391029 | In Pursuit of Fully Flexible Protein-Ligand Docking: Modeling the Bilateral Mechanism of Binding |
| Q28536904 | In silico mechanistic profiling to probe small molecule binding to sulfotransferases |
| Q28552181 | Ligand Docking to Intermediate and Close-To-Bound Conformers Generated by an Elastic Network Model Based Algorithm for Highly Flexible Proteins |
| Q44789723 | Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach. |
| Q51334109 | Modeling loop backbone flexibility in receptor-ligand docking simulations. |
| Q38307338 | Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target. |
| Q37843834 | Molecular motions in drug design: the coming age of the metadynamics method |
| Q36502439 | Pocket-based drug design: exploring pocket space |
| Q30405812 | Pre-existing soft modes of motion uniquely defined by native contact topology facilitate ligand binding to proteins |
| Q38428430 | Protein Flexibility in Drug Discovery: From Theory to Computation |
| Q57990955 | Protein Ligand DockingDocking in Drug DiscoveryDrug Discovery |
| Q26864013 | Protein flexibility in docking and surface mapping |
| Q33659311 | Rapid flexible docking using a stochastic rotamer library of ligands |
| Q33893113 | Recent trends and observations in the design of high-quality screening collections |
| Q38783140 | Receptor-ligand molecular docking |
| Q42081112 | Recipes for the selection of experimental protein conformations for virtual screening |
| Q35369246 | SEABED: Small molEcule activity scanner weB servicE baseD. |
| Q38939477 | Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis |
| Q27022502 | Structure-based virtual screening for drug discovery: a problem-centric review |
| Q34408300 | Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification |
| Q41239235 | SwarmDock and the use of normal modes in protein-protein docking |
| Q28478200 | Systematic exploitation of multiple receptor conformations for virtual ligand screening |
| Q30419540 | Tackling the challenges posed by target flexibility in drug design |
| Q30382761 | Template-based protein modeling: recent methodological advances. |
| Q47234473 | The Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review |
| Q39977512 | The anisotropic network model web server at 2015 (ANM 2.0). |
| Q38594557 | Understanding the challenges of protein flexibility in drug design. |
Search more.